FDA Inspection
Hagop M. Kantarjian, M.D.Hagop M. Kantarjian, M.D. – FDA Inspection, May 5, 2017
Record Details
This FDA Inspection record concerns Hagop M. Kantarjian, M.D., with an inspection on May 5, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 08493f8b-285f-4255-ba4d-0475c6e5c680
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1029979
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 50.27(a)Consent form not approved/signed/dated
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Hagop M. Kantarjian, M.D.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 16, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 17, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 11, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 16, 2011 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Hagop M. Kantarjian, M.D.
- FDA Inspection 1048237 - 2018-03-16
- FDA Inspection 898289 - 2014-09-17
- FDA Inspection 896497 - 2014-09-11
- FDA Inspection 746460 - 2011-09-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.